Monitor Quote Charts Trades News Financials Toplists Alerts Portfolio Level 2 Message Boards
  20/07/2008
07:17:39
Site map		   Help
 
 
 
Incyte (MM)
   
To register click here

Incyte Stock Price INCY

Incyte stock quote | Incyte company information | Incyte Stock Chart | Incyte Stock News

Company Description : A drug discovery and development company focused on developing small molecule drugs to treat serious unmet medical needs. url: www.incyte.com

Name:
Incyte (MM)		 Symbol:
NASDAQ:INCY		 Stock Market:
NASDAQ Stock Market		 Type:
Common Stock		 ISIN:
 Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
-0.28-3.128.78.2710.49.018.588.9472433520:00:02
To register Click hereRegister for free Incyte stock prices.

Incyte reports 'rapid clinical benefits' in Phase I/II study of INCB18424 : BOSTON (Thomson Financial) - Incyte Corp. on Monday said clinical results from a Phase I/II study of INCB18424 in patients with myelofibrosis showed "rapid clinical benefits." INCB18424 is Incyte's orally available...

Free Incyte Stock Charts

Incyte Historical Stock Chart
Incyte Historical Stock Chart
Incyte Monthly Stock Chart
Incyte Monthly Stock Chart		Incyte Intraday stock chart
Incyte Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

Get the Latest Incyte stock Price, quotes, trades and FREE Incyte stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Incyte (INCY) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Incyte News & Message Board Discussion

Latest Incyte News Headlines
DateTimeSource
Headline
06/02/20089:29AMTFNFIncyte reports 'rapid clinical benefits' in Phase I/II study of INCB18424
02/14/20087:32AMTFNFIncyte 4Q loss widens; sees 2008 revenue $3-$3.5 million, excluding Pfizer funds
01/08/20088:36AMTFNFIncyte to report positive clinical results from JAK, 11beta-HSD1 inhibitors
12/10/20074:35PMTFNFIncyte novel JAK Inhibitor INCB18424 shows positive results in Phase I/II trial
Latest Message Board Discussions
DateTimeSource
TitleMore
01/09/20077:01AMFreeGet some of this! 

Incyte Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Incyte company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Incyte Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  4600 8.7 07/18/2008 4:12PM USD


 



PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
43 site:2us nasdaq incy080720 07:17 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )